Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 4,093,000 | 4,177,000 | 4,149,000 | 3,976,000 | 4,529,000 |
| Cost of Goods | 2,264,000 | 2,284,000 | 2,293,000 | 2,005,000 | 2,552,000 |
| Gross Profit | 1,830,000 | 1,893,000 | 1,856,000 | 1,971,000 | 1,977,000 |
| Operating Expenses | 1,911,000 | 2,537,000 | 1,722,000 | 2,228,000 | 1,961,000 |
| Operating Income | -82,000 | -644,000 | 134,000 | -257,000 | 16,000 |
| Other Income | -214,000 | -206,000 | -222,000 | -3,125,000 | -239,000 |
| Pre-tax Income | -296,000 | -850,000 | -88,000 | -3,382,000 | -223,000 |
| Income Tax | 11,000 | -179,000 | 9,000 | -139,000 | -26,000 |
| Net Income Continuous | -307,000 | -671,000 | -97,000 | -3,243,000 | -197,000 |
| Minority Interests | 7,000 | 18,000 | 8,000 | -357,000 | 11,000 |
| Net Income | $-314,000 | $-689,000 | $-105,000 | $-2,886,000 | $-208,000 |
| EPS Basic Total Ops | -0.29 | -0.63 | -0.10 | -2.88 | -0.27 |
| EPS Basic Continuous Ops | -0.28 | -0.61 | -0.09 | -3.18 | -0.19 |
| EPS Diluted Total Ops | -0.29 | -0.63 | -0.10 | -2.87 | -0.27 |
| EPS Diluted Continuous Ops | -0.28 | -0.61 | -0.09 | -3.18 | -0.19 |
| EBITDA(a) | $331,000 | $-194,000 | $577,000 | $125,000 | $490,000 |